CJC-1295 without DAC (Mod GRF 1-29) is a short-acting analogue of growth-hormone-releasing hormone used in growth-hormone-axis research.
$111.30$159.00 was, now $111.30
Form Vial
Select Specification
Selected: Vial · 10mg — $159.00
Bundle & Save
Checking documentation…
Research highlights
A GHRH-analog research peptide without the drug-affinity-complex modification
Research interest: GHRH receptor signaling, peptide pharmacology, growth-hormone axis biology, and endocrine research
This places it within endocrine and growth-factor research involving receptor activation, pituitary signaling, or downstream IGF-related pathways
These research areas can involve different models, endpoints, and analytical methods, so findings should be interpreted within the design and limitations of each study
For laboratory research use only. Not for human or veterinary use.